Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

First approval for new MRI contrast agent from Nycomed

June 6, 1997

Update on Immunomedics diagnostic imaging products

June 6, 1997

Diatide's P829 reliably excludes malignancy in patients with SPN

June 5, 1997

New MRI contrast agent from Nycomed

June 4, 1997

Scios licenses BNP technology to Abbott

June 4, 1997

NIH funds development of Glyko Biomedical's lysosomal storage disease test

June 3, 1997

Metra Biosystems' bone resorption immunoassay cleared in Japan

June 3, 1997

Mallinckrodt describes new imaging agents

June 2, 1997

HIV drug resistance test launched by Murex

June 2, 1997

FDA advisory committee review of EchoGen postponed

June 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...